How a Patient Sparked a Breakthrough: The Story of DHEA at CHR

In this special episode of The Egg Factor, Dr. Norbert Gleicher and Dr. David Barad share the surprising story behind one of CHR’s most influential contributions to fertility care: the use of DHEA (dehydroepiandrosterone) to support women going through fertility treatment.What started as a conversation with a determined patient turned into years of research, dozens of published studies, and a global shift in how fertility specialists view ovarian aging.Listen as Dr. Gleicher and Dr. Barad discuss how DHEA made its way into CHR’s treatment protocols, the science behind it, and how one patient’s curiosity helped spark a breakthrough that has since helped thousands of women around the world.Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning. Our founder, Dr. Norbert Gleicher, performed the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away.Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve.Website: www.thechr.com Facebook: https://www.facebook.com/chrnewyork Instagram: https://www.instagram.com/chrnewyork/ Linkedin:  https://www.linkedin.com/company/centerforhumanreproduction/ Pinterest: https://www.pinterest.com/CenterforHumanReproduction/ TikTok: https://www.tiktok.com/@chrnewyork